The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Orlistat-Global Market Insights and Sales Trends 2024
Synopsis
The global Orlistat market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Orlistat in various end use industries. The expanding demands from the Weight-reducing Aid and Other, are propelling Orlistat market. 120mg Orlistat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 60mg Orlistat segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Orlistat market, driven by demand from China, the second largest economy with some signs of stabilising, the Orlistat market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orlistat, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orlistat market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orlistat market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orlistat sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orlistat covered in this report include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company for Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and ZEIN pharmaceutical, etc.
The global Orlistat market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company for Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
ZEIN pharmaceutical
HISUN
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm
Global Orlistat market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orlistat market, Segment by Type:
120mg Orlistat
60mg Orlistat
Global Orlistat market, by Application
Weight-reducing Aid
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Orlistat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Orlistat market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Orlistat in various end use industries. The expanding demands from the Weight-reducing Aid and Other, are propelling Orlistat market. 120mg Orlistat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 60mg Orlistat segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Orlistat market, driven by demand from China, the second largest economy with some signs of stabilising, the Orlistat market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Orlistat, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Orlistat market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Orlistat market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Orlistat sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Orlistat covered in this report include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company for Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and ZEIN pharmaceutical, etc.
The global Orlistat market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
GSK group
Teva
Sandoz(Novartis)
STADA-VN J.V.Co., Ltd
Hexal AG
National Company for Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
ZEIN pharmaceutical
HISUN
Taj Pharmaceuticals Ltd
Kabir Life Sciences & Research
DM Pharma
China Zhongshan Pharm
Global Orlistat market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Orlistat market, Segment by Type:
120mg Orlistat
60mg Orlistat
Global Orlistat market, by Application
Weight-reducing Aid
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Orlistat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Orlistat Market Overview
1.1 Orlistat Product Overview
1.2 Orlistat Market Segment by Type
1.2.1 120mg Orlistat
1.2.2 60mg Orlistat
1.3 Global Orlistat Market Size by Type
1.3.1 Global Orlistat Market Size Overview by Type (2018-2029)
1.3.2 Global Orlistat Historic Market Size Review by Type (2018-2023)
1.3.3 Global Orlistat Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Orlistat Sales Breakdown by Type (2018-2023)
1.4.2 Europe Orlistat Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Orlistat Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Orlistat Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Orlistat Sales Breakdown by Type (2018-2023)
2 Global Orlistat Market Competition by Company
2.1 Global Top Players by Orlistat Sales (2018-2023)
2.2 Global Top Players by Orlistat Revenue (2018-2023)
2.3 Global Top Players by Orlistat Price (2018-2023)
2.4 Global Top Manufacturers Orlistat Manufacturing Base Distribution, Sales Area, Product Type
2.5 Orlistat Market Competitive Situation and Trends
2.5.1 Orlistat Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Orlistat Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orlistat as of 2022)
2.7 Date of Key Manufacturers Enter into Orlistat Market
2.8 Key Manufacturers Orlistat Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Orlistat Status and Outlook by Region
3.1 Global Orlistat Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Orlistat Historic Market Size by Region
3.2.1 Global Orlistat Sales in Volume by Region (2018-2023)
3.2.2 Global Orlistat Sales in Value by Region (2018-2023)
3.2.3 Global Orlistat Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Orlistat Forecasted Market Size by Region
3.3.1 Global Orlistat Sales in Volume by Region (2024-2029)
3.3.2 Global Orlistat Sales in Value by Region (2024-2029)
3.3.3 Global Orlistat Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Orlistat by Application
4.1 Orlistat Market Segment by Application
4.1.1 Weight-reducing Aid
4.1.2 Other
4.2 Global Orlistat Market Size by Application
4.2.1 Global Orlistat Market Size Overview by Application (2018-2029)
4.2.2 Global Orlistat Historic Market Size Review by Application (2018-2023)
4.2.3 Global Orlistat Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Orlistat Sales Breakdown by Application (2018-2023)
4.3.2 Europe Orlistat Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Orlistat Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Orlistat Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Orlistat Sales Breakdown by Application (2018-2023)
5 North America Orlistat by Country
5.1 North America Orlistat Historic Market Size by Country
5.1.1 North America Orlistat Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Orlistat Sales in Volume by Country (2018-2023)
5.1.3 North America Orlistat Sales in Value by Country (2018-2023)
5.2 North America Orlistat Forecasted Market Size by Country
5.2.1 North America Orlistat Sales in Volume by Country (2024-2029)
5.2.2 North America Orlistat Sales in Value by Country (2024-2029)
6 Europe Orlistat by Country
6.1 Europe Orlistat Historic Market Size by Country
6.1.1 Europe Orlistat Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Orlistat Sales in Volume by Country (2018-2023)
6.1.3 Europe Orlistat Sales in Value by Country (2018-2023)
6.2 Europe Orlistat Forecasted Market Size by Country
6.2.1 Europe Orlistat Sales in Volume by Country (2024-2029)
6.2.2 Europe Orlistat Sales in Value by Country (2024-2029)
7 Asia-Pacific Orlistat by Region
7.1 Asia-Pacific Orlistat Historic Market Size by Region
7.1.1 Asia-Pacific Orlistat Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Orlistat Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Orlistat Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Orlistat Forecasted Market Size by Region
7.2.1 Asia-Pacific Orlistat Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Orlistat Sales in Value by Region (2024-2029)
8 Latin America Orlistat by Country
8.1 Latin America Orlistat Historic Market Size by Country
8.1.1 Latin America Orlistat Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Orlistat Sales in Volume by Country (2018-2023)
8.1.3 Latin America Orlistat Sales in Value by Country (2018-2023)
8.2 Latin America Orlistat Forecasted Market Size by Country
8.2.1 Latin America Orlistat Sales in Volume by Country (2024-2029)
8.2.2 Latin America Orlistat Sales in Value by Country (2024-2029)
9 Middle East and Africa Orlistat by Country
9.1 Middle East and Africa Orlistat Historic Market Size by Country
9.1.1 Middle East and Africa Orlistat Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Orlistat Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Orlistat Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Orlistat Forecasted Market Size by Country
9.2.1 Middle East and Africa Orlistat Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Orlistat Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Orlistat Products Offered
10.1.5 Roche Recent Development
10.2 GSK group
10.2.1 GSK group Company Information
10.2.2 GSK group Introduction and Business Overview
10.2.3 GSK group Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK group Orlistat Products Offered
10.2.5 GSK group Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Orlistat Products Offered
10.3.5 Teva Recent Development
10.4 Sandoz(Novartis)
10.4.1 Sandoz(Novartis) Company Information
10.4.2 Sandoz(Novartis) Introduction and Business Overview
10.4.3 Sandoz(Novartis) Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sandoz(Novartis) Orlistat Products Offered
10.4.5 Sandoz(Novartis) Recent Development
10.5 STADA-VN J.V.Co., Ltd
10.5.1 STADA-VN J.V.Co., Ltd Company Information
10.5.2 STADA-VN J.V.Co., Ltd Introduction and Business Overview
10.5.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.5.4 STADA-VN J.V.Co., Ltd Orlistat Products Offered
10.5.5 STADA-VN J.V.Co., Ltd Recent Development
10.6 Hexal AG
10.6.1 Hexal AG Company Information
10.6.2 Hexal AG Introduction and Business Overview
10.6.3 Hexal AG Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Hexal AG Orlistat Products Offered
10.6.5 Hexal AG Recent Development
10.7 National Company for Pharmaceutical Industry
10.7.1 National Company for Pharmaceutical Industry Company Information
10.7.2 National Company for Pharmaceutical Industry Introduction and Business Overview
10.7.3 National Company for Pharmaceutical Industry Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.7.4 National Company for Pharmaceutical Industry Orlistat Products Offered
10.7.5 National Company for Pharmaceutical Industry Recent Development
10.8 Lunan Pharmaceutical Group Corporation
10.8.1 Lunan Pharmaceutical Group Corporation Company Information
10.8.2 Lunan Pharmaceutical Group Corporation Introduction and Business Overview
10.8.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lunan Pharmaceutical Group Corporation Orlistat Products Offered
10.8.5 Lunan Pharmaceutical Group Corporation Recent Development
10.9 ZEIN pharmaceutical
10.9.1 ZEIN pharmaceutical Company Information
10.9.2 ZEIN pharmaceutical Introduction and Business Overview
10.9.3 ZEIN pharmaceutical Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ZEIN pharmaceutical Orlistat Products Offered
10.9.5 ZEIN pharmaceutical Recent Development
10.10 HISUN
10.10.1 HISUN Company Information
10.10.2 HISUN Introduction and Business Overview
10.10.3 HISUN Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.10.4 HISUN Orlistat Products Offered
10.10.5 HISUN Recent Development
10.11 Taj Pharmaceuticals Ltd
10.11.1 Taj Pharmaceuticals Ltd Company Information
10.11.2 Taj Pharmaceuticals Ltd Introduction and Business Overview
10.11.3 Taj Pharmaceuticals Ltd Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Taj Pharmaceuticals Ltd Orlistat Products Offered
10.11.5 Taj Pharmaceuticals Ltd Recent Development
10.12 Kabir Life Sciences & Research
10.12.1 Kabir Life Sciences & Research Company Information
10.12.2 Kabir Life Sciences & Research Introduction and Business Overview
10.12.3 Kabir Life Sciences & Research Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Kabir Life Sciences & Research Orlistat Products Offered
10.12.5 Kabir Life Sciences & Research Recent Development
10.13 DM Pharma
10.13.1 DM Pharma Company Information
10.13.2 DM Pharma Introduction and Business Overview
10.13.3 DM Pharma Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.13.4 DM Pharma Orlistat Products Offered
10.13.5 DM Pharma Recent Development
10.14 China Zhongshan Pharm
10.14.1 China Zhongshan Pharm Company Information
10.14.2 China Zhongshan Pharm Introduction and Business Overview
10.14.3 China Zhongshan Pharm Orlistat Sales, Revenue and Gross Margin (2018-2023)
10.14.4 China Zhongshan Pharm Orlistat Products Offered
10.14.5 China Zhongshan Pharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Orlistat Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Orlistat Industrial Chain Analysis
11.4 Orlistat Market Dynamics
11.4.1 Orlistat Industry Trends
11.4.2 Orlistat Market Drivers
11.4.3 Orlistat Market Challenges
11.4.4 Orlistat Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Orlistat Distributors
12.3 Orlistat Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
